Debt-to-equity of SEELOS THERAPEUTICS, INC. from 31 Mar 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SEELOS THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Jun 2024.
  • SEELOS THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Jun 2024 was -114%, a 52% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

SEELOS THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -114% +126% +52% 30 Jun 2024
Q1 2024 -119% -4938% -102% 31 Mar 2024
Q4 2023 -136% -306% -180% 31 Dec 2023
Q3 2023 -159% -240% -298% 30 Sep 2023
Q2 2023 -240% -282% -666% 30 Jun 2023
Q1 2023 4819% +4793% +18533% 31 Mar 2023
Q4 2022 170% +145% +591% 31 Dec 2022
Q3 2022 80% +55% +212% 30 Sep 2022
Q2 2022 42% +6% +17% 30 Jun 2022
Q1 2022 26% -77% -75% 31 Mar 2022
Q4 2021 25% -125% -84% 31 Dec 2021
Q3 2021 26% -228% -90% 30 Sep 2021
Q2 2021 36% -169% -82% 30 Jun 2021
Q1 2021 103% -95% -48% 31 Mar 2021
Q4 2020 150% -129% -46% 31 Dec 2020
Q3 2020 253% +67% +36% 30 Sep 2020
Q2 2020 206% +9926% 30 Jun 2020
Q1 2020 197% +431% 31 Mar 2020
Q4 2019 279% +359% 31 Dec 2019
Q3 2019 187% +269% 30 Sep 2019
Q2 2019 -9720% -10862% -951% 30 Jun 2019
Q1 2019 -233% -324% -357% 31 Mar 2019
Q4 2018 -80% -173% -186% 31 Dec 2018
Q3 2018 -82% -428% -124% 30 Sep 2018
Q2 2018 1142% +1599% 30 Jun 2018
Q1 2018 91% +295% 31 Mar 2018
Q4 2017 93% +288% 31 Dec 2017
Q3 2017 345% +543% 30 Sep 2017
Q2 2017 -457% -258% -129% 30 Jun 2017
Q1 2017 -204% +36% +15% 31 Mar 2017
Q4 2016 -195% +154% +44% 31 Dec 2016
Q3 2016 -197% +635% +76% 30 Sep 2016
Q2 2016 -200% -632% -146% 30 Jun 2016
Q1 2016 -240% 31 Mar 2016
Q4 2015 -349% 31 Dec 2015
Q3 2015 -832% 30 Sep 2015
Q2 2015 432% 30 Jun 2015
Q4 2013 150% +63% +72% 31 Dec 2013
Q3 2013 186% +105% +129% 30 Sep 2013
Q2 2013 152% +61% +68% 30 Jun 2013
Q1 2013 138% +30% +28% 31 Mar 2013
Q4 2012 87% 31 Dec 2012
Q3 2012 81% 30 Sep 2012
Q2 2012 91% 30 Jun 2012
Q1 2012 108% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.